Danaher (NYSE:DHR) Given New $270.00 Price Target at JPMorgan Chase & Co.

Key Points

• JPMorgan Chase & Co. has increased Danaher’s price target from $260.00 to $270.00, reflecting a potential upside of 23.83% from its current price.
• Danaher recently reported quarterly earnings of $1.89 per share, exceeding analyst expectations of $1.72, with revenues of $6.05 billion, up 4.4% year-over-year.
• Despite a dip in stock prices by 1.2%, the company maintains a strong investor outlook, with the majority of research analysts rating it as a "Buy."

Danaher (NYSE:DHR - Get Free Report) had its target price lifted by equities researchers at JPMorgan Chase & Co. from $260.00 to $270.00 in a research note issued to investors on Wednesday,MarketScreener reports. The brokerage presently has an "overweight" rating on the conglomerate's stock. JPMorgan Chase & Co.'s price objective indicates a potential upside of 23.83% from the company's current price.

Other equities analysts have also issued research reports about the company. Deutsche Bank Aktiengesellschaft raised their price objective on Danaher from $235.00 to $250.00 and gave the stock a "buy" rating in a report on Wednesday. Royal Bank Of Canada set a $241.00 price objective on Danaher in a report on Tuesday, September 2nd. Rothschild Redb lowered Danaher from a "strong-buy" rating to a "hold" rating in a report on Wednesday, October 8th. Robert W. Baird raised their price target on Danaher from $229.00 to $236.00 and gave the stock an "outperform" rating in a report on Wednesday, October 15th. Finally, Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target on the stock in a report on Friday, July 11th. Eighteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $248.92.

Danaher Stock Down 1.2%

Shares of NYSE DHR traded down $2.74 during mid-day trading on Wednesday, hitting $218.03. The company had a trading volume of 560,296 shares, compared to its average volume of 4,235,630. Danaher has a 1-year low of $171.00 and a 1-year high of $260.88. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The company has a market capitalization of $156.12 billion, a PE ratio of 46.39, a price-to-earnings-growth ratio of 3.01 and a beta of 0.77. The business's 50-day simple moving average is $202.07 and its 200 day simple moving average is $197.59.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts' consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion for the quarter, compared to analysts' expectations of $6 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.Danaher's quarterly revenue was up 4.4% on a year-over-year basis. During the same period last year, the firm earned $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts predict that Danaher will post 7.63 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of the firm's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 11.20% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Danaher

Hedge funds and other institutional investors have recently modified their holdings of the stock. MGO One Seven LLC raised its position in shares of Danaher by 485.7% during the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after purchasing an additional 20,813 shares during the last quarter. Chicago Capital LLC boosted its holdings in shares of Danaher by 11.6% during the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate's stock worth $2,634,000 after purchasing an additional 1,391 shares during the last quarter. UniSuper Management Pty Ltd boosted its holdings in shares of Danaher by 1.6% during the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate's stock worth $34,954,000 after purchasing an additional 2,667 shares during the last quarter. Asahi Life Asset Management CO. LTD. acquired a new stake in shares of Danaher during the first quarter worth $539,000. Finally, Horizon Financial Services LLC boosted its holdings in shares of Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after purchasing an additional 8,160 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.